Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability

BACKGROUND: Oral glucocorticoids (GCs) have been shown to be effective in reducing the inflammatory symptoms of rheumatoid arthritis, but their use is not supported by evidence in spondyloarthritis (SpA). Modified-release (MR) oral prednisone taken at bedtime has been shown to be more effective than...

Descripción completa

Detalles Bibliográficos
Autores principales: Bandinelli, Francesca, Scazzariello, Francesco, Pimenta da Fonseca, Emanuela, Barreto Santiago, Mittermayer, Marcassa, Claudio, Nacci, Francesca, Matucci Cerinic, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115695/
https://www.ncbi.nlm.nih.gov/pubmed/27881910
http://dx.doi.org/10.2147/DDDT.S115099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115695/
https://www.ncbi.nlm.nih.gov/pubmed/27881910
http://dx.doi.org/10.2147/DDDT.S115099

Ejemplares similares